An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these accounts directly for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with numerous of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Worries
However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and customer laws, risking fines, prosecution or prison.
Platform Response and Content Removal
According to the social media company, the platform has taken down violative content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of weight loss, glowing reviews and step-by-step instructions for preparing or administering at home.
Within minutes of joining one community, a vendor posted contact information, where the majority of transactions occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.
Product Information and Pricing
Inside these communities, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service stated it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to possibly significant health risks”.
